Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness

NCT00457002 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6758

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis
Pulmonary Embolism

Interventions

DRUG: Apixaban
DRUG: Enoxaparin

Sponsor

Bristol-Myers Squibb